Chimeric SOD2/3 inhibits at the endothelial-neutrophil interface to limit vascular dysfunction in ischemia-reperfusion.

After an ischemic episode, reperfusion causes profound oxidative stress in the vasculature of the afflicted tissue/organ. The dysregulated accumulation of reactive oxygen species (ROS), such as superoxide, has been closely linked to the production and release of proinflammatory mediators, a profound increase in adhesion molecule expression by the vascular endothelium, and infiltration of neutrophils during ischemia-reperfusion (I/R). Superoxide dismutase (SOD) has been shown to protect tissues and organs against I/R-induced injury; however, the drug had to be continuously perfused or kidneys had to be occluded to prevent clearance. We used intravital microscopy, a system that allowed us to visualize neutrophil-endothelial interactions within the mesenteric postcapillary venules of cats subjected to I/R and tested the hypothesis that I/R-induced neutrophil recruitment was inhibited by treatment with SOD2/3. SOD2/3 is a chimeric fusion gene product that contains the mature SOD2 as well as the COOH-terminal "tail" of SOD3 and, unlike the three naturally occurring SODs (SOD1, SOD2, and SOD3), which bear a net negative charge at pH 7.4, SOD2/3 is positively charged and physiologically stable. Our results suggest that not only does SOD2/3 have a much greater efficacy in vivo than the native human SOD2, but its administration prevents I/R-induced neutrophil-endothelial cell interactions and microvascular dysfunction. Moreover, our data support the hypothesis that reactive oxidants mediate I/R-induced injury and that the chimeric recombinant SOD2/3 has the potential to be a therapeutic agent against this debilitating illness.

[1]  P. Kubes,et al.  Enhanced S-Nitroso-Albumin Formation From Inhaled NO During Ischemia/Reperfusion , 2004, Circulation research.

[2]  B. Gao,et al.  Role of NADPH oxidase-derived superoxide in reduced size liver ischemia and reperfusion injury. , 2004, Archives of biochemistry and biophysics.

[3]  B. Gao,et al.  Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[4]  B. Gao,et al.  Regulation of postischemic liver injury following different durations of ischemia. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[5]  D. Granger,et al.  Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. , 2003, American journal of physiology. Heart and circulatory physiology.

[6]  T. Begenisich,et al.  Molecular identification of Ca2+-activated K+ channels in parotid acinar cells. , 2003, American journal of physiology. Cell physiology.

[7]  B. Gao,et al.  A novel heparin-binding, human chimeric, superoxide dismutase improves myocardial preservation and protects from ischemia-reperfusion injury. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  Guan-Zhen Yang,et al.  High-level expression of human extracellular superoxide dismutase in Escherichia coli and insect cells. , 2002, Protein expression and purification.

[9]  H. Drexler,et al.  Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. , 2000, Circulation.

[10]  D. Granger.  Ischemia‐Reperfusion: Mechanisms of Microvascular Dysfunction and the Influence of Risk Factors for Cardiovascular Disease , 1999, Microcirculation.

[11]  K E Norman,et al.  Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. , 1998, The Journal of clinical investigation.

[12]  P. Kubes,et al.  Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. , 1998, The Journal of clinical investigation.

[13]  P. Kubes,et al.  Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. , 1997, Circulation.

[14]  J. Wang,et al.  Plasma factors augment neutrophil and endothelial cell activation during aortic surgery. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[15]  H. Redmond,et al.  Immunological and physiological responses to aortic surgery: Effect of reperfusion on neutrophil and monocyte activation and pulmonary function , 1997, The British journal of surgery.

[16]  E. Kunkel,et al.  Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. , 1996, Circulation research.

[17]  Sidhartha Tan,et al.  Gastric intramucosal pH and multiple organ injury: impact of ischemia-reperfusion and xanthine oxidase. , 1996, Critical care medicine.

[18]  C. Håkansson,et al.  Multiple-system organ damage resulting from prolonged hepatic inflow interruption. , 1996, Archives of surgery.

[19]  D. Anderson,et al.  Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. , 1996, The American journal of physiology.

[20]  P. Kubes,et al.  Nitric oxide inhibits numerous features of mast cell-induced inflammation. , 1996, Circulation.

[21]  P. Kubes,et al.  Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. , 1995, The Journal of clinical investigation.

[22]  S. Matalon,et al.  Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. , 1995, The American journal of physiology.

[23]  M. Conte,et al.  Pulmonary failure following lower torso ischemia: clinical evidence for a remote effect of reperfusion injury. , 1995, The American surgeon.

[24]  J. McCord,et al.  Neutrophil-generated free radicals: possible mechanisms of injury in adult respiratory distress syndrome. , 1994, Environmental health perspectives.

[25]  P. Kubes,et al.  NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. , 1994, The American journal of physiology.

[26]  D. Liggitt,et al.  Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. , 1993, The Journal of clinical investigation.

[27]  A. M. Lefer,et al.  Monoclonal Antibody to L‐Selectin Attenuates Neutrophil Accumulation and Protects Ischemic Reperfused Cat Myocardium , 1993, Circulation.

[28]  S. Marklund,et al.  The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. , 1992, The Journal of biological chemistry.

[29]  J. Repine,et al.  Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. , 1992, The American journal of physiology.

[30]  M. G. Oliver,et al.  Morphologic assessment of leukocyte-endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion , 1991, Inflammation.

[31]  A. M. Lefer,et al.  Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. , 1991, The Journal of clinical investigation.

[32]  J D Chambers,et al.  Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[34]  M. Grisham,et al.  Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. , 1989, The American journal of physiology.

[35]  D. Granger,et al.  Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. , 1988, The American journal of physiology.

[36]  S. Marklund,et al.  Plasma clearance of human extracellular-superoxide dismutase C in rabbits. , 1988, The Journal of clinical investigation.

[37]  L. Tibell,et al.  Expression of human extracellular superoxide dismutase in Chinese hamster ovary cells and characterization of the product. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Grisham,et al.  Role of neutrophils in ischemia-reperfusion-induced microvascular injury. , 1987, The American journal of physiology.

[39]  S. Marklund,et al.  Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. , 1986, Annals of the rheumatic diseases.

[40]  B. Seligmann,et al.  Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. , 1986, The Journal of clinical investigation.

[41]  S. Marklund.  Product of extracellular‐superoxide dismutase catalysis , 1985, FEBS letters.

[42]  S. Marklund.  Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. , 1984, The Biochemical journal.

[43]  A. Baret,et al.  Pharmacokinetic and anti-inflammatory properties in the rat of superoxide dismutases (Cu SODs and Mn SOD) from various species. , 1984, Biochemical pharmacology.

[44]  S. Marklund.  Properties of extracellular superoxide dismutase from human lung. , 1984, The Biochemical journal.

[45]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[46]  S. Marklund,et al.  Human copper-containing superoxide dismutase of high molecular weight. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[47]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[48]  T. Kizaki,et al.  Tissue distribution of immunoreactive mouse extracellular superoxide dismutase , 1998 .

[49]  D. Carden,et al.  Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins , 1998 .

[50]  T. Aw,et al.  Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. , 1995, Circulation research.

[51]  N. Christou,et al.  Exudative neutrophils. Modulation of microbicidal function in the inflammatory microenvironment. , 1994, Archives of surgery.

[52]  I. Fridovich.  Superoxide and Superoxide Dismutases , 1977 .